Abstract
Introduction: Previous research has described physician prescribing patterns and physician experiences that might result in barriers to treatment of patients with psoriasis. While some research dedicated to patient-identified barriers exists, the global psoriasis patient population remains undertreated, and would benefit from further clinical investigation. Self-reported barriers of patients to care and the impact of disease severity on that aspect of the patient experience are important impediments to consider.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
